Amgen Inc. Tax Withholding Paid on Stock Awards
Amgen Inc. (AMGN) reported Tax Withholding Paid on Stock Awards of $137.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2020-02-12
- Amgen Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2016-12-31 was $6.00M, a 14.29% decline year-over-year.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2016-09-30 was -$8.00M, a 300.00% decline year-over-year.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2015-12-31 was $7.00M.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2015-09-30 was $4.00M.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for fiscal 2019 was $137.00M, a 8.73% increase from fiscal 2018.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for fiscal 2018 was $126.00M, a 34.03% decline from fiscal 2017.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for fiscal 2017 was $191.00M, a 26.54% decline from fiscal 2016.
- Amgen Inc. payment, tax withholding, share-based payment arrangement for fiscal 2016 was $260.00M, a 35.16% decline from fiscal 2015.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2019-12-31 | $137.00M 10-K · filed 2020-02-12 | |||
| 2018-12-31 | $126.00M 10-K · filed 2020-02-12 | |||
| 2017-12-31 | $191.00M 10-K · filed 2020-02-12 | |||
| 2016-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$2.00M derived: sum of 2 quarters · filed 2019-02-13 | $260.00M 10-K · filed 2019-02-13 | |
| 2016-09-30 | -$8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $254.00M 10-Q · filed 2016-10-28 | ||
| 2016-06-30 | $262.00M 10-Q · filed 2016-07-29 | |||
| 2015-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $11.00M derived: sum of 2 quarters · filed 2018-02-13 | $401.00M 10-K · filed 2018-02-13 | |
| 2015-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $394.00M 10-Q · filed 2016-10-28 | ||
| 2015-06-30 | $390.00M 10-Q · filed 2016-07-29 | |||
| 2014-12-31 | $225.00M 10-K · filed 2017-02-14 | |||
| 2013-12-31 | $139.00M 8-K · filed 2016-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |